Answers are grounded in this paper and cite their sources.
This study demonstrates that integrating liver stiffness measurement with tumour-based criteria refines the identification of patients at high biological risk of recurrence after curative resection for hepatocellular carcinoma. By addressing the limitations of purely tumour-centric selection strategies (i.e IMbrave050 criteria), it highlights the prognostic relevance of the underlying liver disease in shaping post-resection outcomes. Incorporation of this approach into clinical research and trial design could improve risk stratification and patient selection for adjuvant therapies, while avoiding overgeneralisation given the retrospective, single-centre nature of the study.
No takes yet. Share an insight, caveat, or question.
Serenari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: